Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Altered fractionation].

Masakazu Hasegawa1, Masamichi Nishio, Miyako Myoujin

  • 1Dept. of Radiology, National Hospital Organization Hokkaido Cancer Center.

Gan to Kagaku Ryoho. Cancer & Chemotherapy
|April 14, 2006
PubMed
Summary

Altered fractionation (AF) modifies radiotherapy schedules to improve cancer treatment. While effective for local control in some cancers, its impact on survival and standard treatment status remains debated, especially with advancing techniques.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

DVH parameters and gastrointestinal/genitourinary toxicities in moderate hypofractionated salvage radiotherapy after radical prostatectomy.

Journal of radiation research·2026
Same author

Optimal combination of heart and lung dose parameters in radiotherapy for locally advanced non-small cell lung carcinoma: a multicenter retrospective study.

Journal of radiation research·2026
Same author

Normal tissue complication probability model for severe radiation-induced lymphopenia in patients with pancreatic cancer treated with concurrent chemoradiotherapy.

Physics and imaging in radiation oncology·2025
Same author

Magnetic resonance cholangiopancreatography using T2 preparation pulse: quantitative and qualitative analyses.

Acta radiologica (Stockholm, Sweden : 1987)·2023
Same author

Brain metastases in Japanese NSCLC patients: prognostic assessment and the use of osimertinib and immune checkpoint inhibitors-retrospective study.

Radiation oncology (London, England)·2023
Same author

Clinical relevance of addition of conventional treatment to concurrent chemoradiotherapy in patients with FIGO stage III-IV cervical cancer: a retrospective analysis of a Japanese cohort.

Japanese journal of clinical oncology·2021

Area of Science:

  • Radiation Oncology
  • Cancer Biology
  • Radiotherapy Techniques

Background:

  • Altered fractionation (AF) is a key biological strategy to modify conventional radiotherapy schedules.
  • AF includes hyperfractionation (HF) and accelerated hyperfractionation (AHF), aiming to enhance tumor control and minimize normal tissue damage.
  • Despite reported efficacy in various cancers like head and neck, AF is not widely adopted as standard therapy.

Purpose of the Study:

  • To review the role and efficacy of altered fractionation (AF) in cancer radiotherapy.
  • To discuss the challenges and controversies surrounding the adoption of AF as a standard treatment.
  • To highlight the emerging importance of dose-fractionation-time relationships, including hypofractionation, in the context of stereotactic irradiation.

Main Methods:

Related Experiment Videos

  • Literature review of studies on altered fractionation in radiotherapy.
  • Analysis of clinical outcomes, including local control and survival, for various cancer types treated with AF.
  • Discussion of the biological rationale behind different AF schedules (HF, AHF).

Main Results:

  • AF, including HF and AHF, shows promise for improving local control in cancers such as head and neck, lung, bladder, and glioma.
  • However, improved local control does not consistently translate to enhanced patient survival.
  • Accelerated hyperfractionation (AHF) is a standard for small cell lung cancer but remains controversial.
  • Altered fractionation is not yet a standard treatment for most investigated cancers.

Conclusions:

  • Altered fractionation strategies offer potential benefits in radiotherapy but require further investigation to establish their role in improving overall survival.
  • The evolving landscape of radiotherapy, particularly stereotactic irradiation, necessitates a deeper understanding of dose-fractionation-time relationships and hypofractionation.
  • Further research is needed to optimize AF protocols and determine their definitive place in standard oncological care.